Publications of Simone Roeh
All genres
Journal Article (35)
21.
Journal Article
22 (12), pp. 2023 - 2028 (2019)
Identity domains capture individual differences from across the behavioral repertoire. NATURE NEUROSCIENCE 22.
Journal Article
50 (10), pp. 2651 - 2660 (2019)
The Atherosclerosis Risk Variant rs2107595 Mediates Allele-Specific Transcriptional Regulation of HDAC9 via E2F3 and Rb1. STROKE 23.
Journal Article
11, 83 (2019)
Identification of dynamic glucocorticoid-induced methylation changes at the FKBP5 locus. CLINICAL EPIGENETICS 24.
Journal Article
116 (23), pp. 11370 - 11379 (2019)
Epigenetic upregulation of FKBP5 by aging and stress contributes to NF-kappa B-driven inflammation and cardiovascular risk. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 25.
Journal Article
99 (2), pp. 389 - 403 (2018)
The Role of m6A/m-RNA Methylation in Stress Response Regulation. NEURON 26.
Journal Article
11, 39 (2018)
HAM-TBS: high-accuracy methylation measurements via targeted bisulfite sequencing. EPIGENETICS & CHROMATIN 27.
Journal Article
17, pp. 1 - 16 (2018)
Sex dependent impact of gestational stress on predisposition to eating disorders and metabolic disease. MOLECULAR METABOLISM 28.
Journal Article
9, 1596 (2018)
Placental miR-340 mediates vulnerability to activity based anorexia in mice. NATURE COMMUNICATIONS 29.
Journal Article
19, 61 (2018)
Correction to: Lifetime stress accelerates epigenetic aging in an urban, African American cohort: relevance of glucocorticoid signaling (vol 16, 266, 2015). GENOME BIOLOGY 30.
Journal Article
8 (4), pp. 1 - 11 (2017)
Sequencing on the SOLiD 5500xl System - in-depth characterization of the GC bias. Nucleus 31.
Journal Article
41 (13), pp. 3025 - 3031 (2016)
Functional Impact of An ADHD-Associated DIRAS2 Promoter Polymorphism. NEUROPSYCHOPHARMACOLOGY 32.
Journal Article
41 (13), pp. 3025 - 3031 (2016)
Functional Impact of An ADHD-Associated DIRAS2 Promoter Polymorphism. NEUROPSYCHOPHARMACOLOGY 33.
Journal Article
16, 266 (2015)
Lifetime stress accelerates epigenetic aging in an urban, African American cohort: relevance of glucocorticoid signaling. GENOME BIOLOGY 34.
Journal Article
10 (10), e0139516 (2015)
Re-Annotator: Annotation Pipeline for Microarray Probe Sequences. PLOS ONE 35.
Journal Article
8 (7), e68645 (2013)
Functional Coding Variants in SLC6A15, a Possible Risk Gene for Major Depression. PLOS ONE Conference Paper (4)
36.
Conference Paper
83 (9, Suppl.), 192, p. S77 - S77 (2018)
Investigation of Prenatal Stress in the Cerebral Organoid Model: A Focus on Cell-Type Specific Responses Following Glucocorticoid Exposure. 73rd Annual Scientific Convention and Meeting, Annual
Meeting of the Society of Biological Psychiatry (SOBP), New York, NY, May 10, 2018 - May 12, 2018. Biological Psychiatry 37.
Conference Paper
83 (9), F179, p. S308 - S308 (2018)
Epigenetic Biomarkers in Women With Posttraumatic Stress Disorder After CRF1 Receptor Antagonist Treatment. 73rd Annual Scientific Convention and Meeting of the Society-of-Biological-Psychiatry (SOBP), New York, NY, May 10, 2018 - May 12, 2018. BIOLOGICAL PSYCHIATRY 38.
Conference Paper
83 (9), F121, pp. S284 - S285 (2018)
Investigating Glucocorticoid Receptor Binding in Lymphoblastoid Cell Lines. 73rd Annual Scientific Convention and Meeting of the Society-of-Biological-Psychiatry (SOBP), New York, NY, May 10, 2018 - May 12, 2018. BIOLOGICAL PSYCHIATRY 39.
Conference Paper
42, W158, p. S576 - S576 (2017)
Investigation of Prenatal Stress in the Cerebral Organoid Model: A Focus on Cell-Type Specific Responses Following Glucocorticoid Exposure. 56th Annual Meeting of the American College of Neuropsychopharmacology
(ACNP), Palm Springs, CA, December 03, 2017 - December 07, 2017. NEUROPSYCHOPHARMACOLOGY Meeting Abstract (4)
40.
Meeting Abstract
87, p. 103 - 103. World Congress of Psychiatric Genetics (WCPG), Singapore, SINGAPORE, October 15, 2024 - October 19, 2024. (2024)
CHARACTERIZING SEX-SPECIFIC EFFECTS OF EARLY LIFE ADVERSITY ON THE ADULTHOOD BRAIN TRANSCRIPTOME USING A TRANSLATIONAL MOUSE MODEL. In EUROPEAN NEUROPSYCHOPHARMACOLOGY,